Healius Ltd (ASX: HLS) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Healius Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Healius Ltd (ASX: HLS)
Latest News
⏸️ Investing
ALL ORDINARIES finishes higher Monday: 8 shares you missed
⏸️ Investing
Here's why these 4 ASX shares started the week with BIG gains
⏸️ Investing
Why the Pro Medicus Limited share price is going nuts this morning
⏸️ Investing
Why these 4 shares are getting pummelled today
⏸️ Investing
Why the Capitol Health Ltd share price went nuts this afternoon
⏸️ Investing
Why the Primary Health Care Limited share price has crashed today
⏸️ Investing
Why these 4 ASX shares have stormed higher today
⏸️ Investing
These 3 IVF providers could give your portfolio a bump in growth
⏸️ Investing
Why these 4 shares are getting PUNISHED today
⏸️ Investing
Primary Health Care Limited loses CEO: Should you buy?
⏸️ Investing
Why Bellamy's Australia Ltd is one of 4 shares getting the punt today
⏸️ Investing
Why these 6 shares are getting CRUSHED today
Frequently Asked Questions
-
Yes, Healius has historically paid two fully franked shareholder dividends a year.
-
Healius has generally paid its shareholder dividends in March/April and September/October.
-
Healius Ltd listed on the ASX on 3 July 1998.
HLS ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Healius Ltd
Healius Ltd (ASX: HLS) operates a network of pathology laboratories, diagnostic imaging centres, and day hospitals across Australia.
The company is Australia's second-largest pathology provider with around 2,000 collection sites and almost 100 pathology laboratories operating under a portfolio of brand names. The company says one in three pathology samples taken in Australia is tested in a Healius laboratory. It also operates around 150 imaging centres in public and private hospitals, medical centres, and community centres.
The company has identified its short-stay and day hospitals as a growth segment. It currently operates 15 day hospitals as well as four major IVF clinics.
